Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Mine Yarim
    Professor
    Yeditepe University
    Turkey
    myarim@yeditepe.edu.tr
    GJCT

    Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Rui-An Wang
    Professor
    Department of Pathology and Pathobiology
    The Fourth Military Medical University
    China
    wangra@fmmu.edu.cn
    GJCT

    Research Interest: Theory and Mechanisms of Carcinogenesis and Metastasis; Breast Cancer; Endocrinology


    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    c.wong@adelaide.edu.au
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Mirela Sedic
    Assistant Professor
    Department of Biotechnology
    University of Rijeka
    Croatia
    msedic@biotech.uniri.hr
    GJCT

    Research Interest: Her Major Scientific Interests Include Cancer Biology And Treatment, With Particular Emphasis On Sphingolipid Signalling In Cancer.


    More Info.
    Manuel Aureliano
    Associate Professor
    University of Algarve
    Portugal
    maalves@ualg.pt
    GJCT

    Research Interest: Toxicology And Pharmaceutical Applications Of Decavanadate; Ii) Muscle Contraction And Regulation; Iii) Insulin Mimetic Compounds.


    More Info.
    Mostafa Shawky Ibrahim El-Haddad
    Assistant Professor
    Department of Clinical Oncology
    Cairo University
    Egypt
    mostafa@mostafaelhaddad.com
    GJCT

    Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

    More Info.
    Stefania Staibano
    Professor
    Department of Pathology
    University of Naples Federico II
    Italy
    staibano@unina.it
    GJCT

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology


    More Info.
    Gang Du
    Shanghai Jiaotong University
    China
    gdu@dbm.ecnu.edu.cn
    GJCT
    Research Interest: Clinical Tumour Classification And Diagnosis, Data Mining In Healthcare, Clinical Pathway Modeling, Simulation And Scheduling Optimization, Decision-Making In Healthcare  
    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Karim Essani
    Professor
    Department of Biological Sciences
    Western Michigan University
    USA
    karim.essani@wmich.edu
    GJCT
    Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
    More Info.
    Tsuyoshi Shirakawa
    Department of Oncology
    Miyazaki University Hospital
    Japan
    twriver1979@gmail.com
    GJCT

    Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study


    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine
    India
    manzooriiim@gmail.com
    GJCT

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    View more
    mendeley

    Investigation of the effectiveness of ECOLAB ’Drape ArmourTM’ Radiation Protection in limiting eye-lens doses of healthcare personnel exposed to ionizing radiation during gastroenterology - interventional radiology procedures

    DOI Logo 10.17352/2581-5407.000048

    Published On: October 20, 2022 | Pages: 046 - 050

    Author(s): Fulvio IM Fucilli*, Giuseppe Di Giovanni, Alessandro Mastrorocco, Matteo Ninni, Piero Loprete, Isa De Crudis, Massimiliano Marano, Antonio Santomauro and Fabio Fucilli

    ORCID: 0000-0002-1132-0363

    Abstract View Full Article View
    mendeley

    The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

    DOI Logo 10.17352/2581-5407.000047

    Published On: October 11, 2022 | Pages: 040 - 045

    Author(s): Aslı Altun, Nurten Kara, Şengül Tural*, Alişan Yıldıran and Leman Tomak

    ORCID: 0000-0002-8946-8165

    Abstract View Full Article View
    mendeley

    A first comprehensive look at the order-disorder nature of RTK KIT native and carcinogenic targets

    DOI Logo 10.17352/2581-5407.000046

    Published On: October 07, 2022 | Pages: 036 - 039

    Author(s): Luba Tchertanov* and Julie Ledoux

    ORCID: 0000-0001-6600-5494

    Abstract View Full Article View
    mendeley

    Photodynamic therapy in a pleural cavity using monte carlo simulations with 2D/3D Graphical Visualization

    DOI Logo 10.17352/2581-5407.000045

    Published On: September 29, 2022 | Pages: 034 - 035

    Author(s): Beeson K, Parilov E, Mary Potasek*, Zhu T, Sun H and Sourvanos D
    Abstract View Full Article View
    mendeley

    Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases

    DOI Logo 10.17352/2581-5407.000044

    Published On: March 23, 2022 | Pages: 021 - 033

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Surgery, Chemotherapy and Radiotherapy May Promote Cancer Growth Speeds and Shorten Patient Lives

    DOI Logo 10.17352/2581-5407.000043

    Published On: March 19, 2022 | Pages: 001 - 020

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Patient’s experiences on receiving radiation therapy for head and neck cancer pre, pending and post treatment: A qualitative study at Bugando medical centre Mwanza, Tanzania

    DOI Logo 10.17352/2581-5407.000042

    Published On: August 23, 2021 | Pages: 046 - 049

    Author(s): Francis Kazoba* and Juston John
    Abstract View Full Article View    
    mendeley

    Assessment of the role of multimodality imaging for treatment volume definition of intracranial ependymal tumors: An original article

    DOI Logo 10.17352/2581-5407.000041

    Published On: July 06, 2021 | Pages: 043 - 045

    Author(s): Ferrat Dincoglan, Omer Sager*, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

    DOI Logo 10.17352/2581-5407.000040

    Published On: May 19, 2021 | Pages: 035 - 042

    Author(s): Benjamin A Babalola*, Gboyega E Adebami and Samuel E Akinsuyi
    Abstract View Full Article View    
    mendeley

    Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)

    DOI Logo 10.17352/2581-5407.000039

    Published On: March 15, 2021 | Pages: 031 - 034

    Author(s): Omer Sager*, Ferrat Dincoglan, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT

    Google Reviews 11